Post-authorization Safety Study of Euforvac-Hib Vaccine for Active Primary Immunization in Infants From 6 Weeks

Clinical trial NCT02257645 · UNKNOWN

Trial details

NCT number: NCT02257645
Sponsor: LG Life Sciences
Status: UNKNOWN
Study type: OBSERVATIONAL

Diphtheria Tetanus Pertussis Hepatitis B Haemophilus Influenza Type B

Start date: 2015-03-01
Primary completion: 2016-05-01
Enrollment: 3000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.